Online social support for third level students - A pilot feasibility trial of the PSYCHE-MOST intervention.

ISRCTN ISRCTN15520701
DOI https://doi.org/10.1186/ISRCTN15520701
Secondary identifying numbers RL-2020-007
Submission date
19/04/2024
Registration date
16/07/2024
Last edited
16/07/2024
Recruitment status
No longer recruiting
Overall study status
Ongoing
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
In many European countries, a significant portion of young adults engage in some form of education until their early twenties. A 2017 study conducted by the World Health Organization (WHO) involving approximately 14,000 students across eight countries, including Northern Ireland, revealed that around one in three individuals exhibited symptoms indicative of at least one common mental disorder as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), such as anxiety, mood disorders, or substance-related disorders.

With a noticeable increase in individuals seeking help for mental health concerns in recent times, digital health interventions—mental health support delivered through web-based or mobile-based platforms—hold significant promise in enhancing outcomes, broadening access, and addressing the growing demand for mental health services.

One such approach aimed at enhancing mental health recovery among young adults is Moderated Online Social Therapy (MOST), as proposed by Alvarez-Jimenez and colleagues in 2021. Initially developed as a digital mental health platform available via both web interface and dedicated app, MOST offers a low-intensity, cost-effective, and engaging method to sustain the benefits of specialized Early Intervention for Psychosis (EIP) services. Studies have shown its effectiveness in facilitating return to education and employment while reducing the need for emergency care. It has also undergone a trial involving young individuals aged 12 to 25 who sought help for mental health issues.

MOST comprises evidence-based online therapy content supplemented by therapist interaction, alongside a community feature resembling a Facebook-style platform, supported and moderated by peer support workers.

The objective of the current study is twofold: firstly, to assess the feasibility and acceptability of MOST among individuals who recently accessed a university counseling service, and secondly, to provide preliminary data on the effectiveness of MOST, laying the groundwork for a definitive randomized controlled trial.

Who can participate?
Adults aged 18 - 35 years, self reporting mental health difficulties of longer than one year in duration.

What does the study involve?
The study involves participating in a 26 week online digital intervention that consists of a therapy journey supported by fortnightly contact with a clinician, and an online social community supported by fortnightly contact with peer support workers.

What are the possible benefits and risks of participating?
The potential benefits are to wellbeing (e.g. reduction of clinical symptoms of anxiety/low mood) and improvement of social function. No risks have been identified to date with participation. In addition, participants complete an assessment battery at baseline, 3months and 6 months.

Where is the study run from?
University of Galway (Ireland)

When is the study starting and how long is it expected to run for?
September 2019 to December 2025

Who is funding the study?
Health Research Board (Ireland)

Who is the main contact?
Prof Gary Donohoe, gary.donohoe@universityofgalway.ie

Study website

Contact information

Prof Gary Donohoe
Public, Scientific, Principal Investigator

School of Psychology, University of Galway, University Road
Galway
H912TK33
Ireland

ORCiD logoORCID ID 0000-0003-3037-7426
Phone +353 91495122
Email gary.donohoe@universityofgalway.ie

Study information

Study designInterventional pilot feasibility single center randomized controlled study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)University/medical school/dental school
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet.
Scientific titleImproving Psychosocial Supports in youth mental health (PSYCHE) - A pilot feasibility randomised controlled trial of Moderated Online Social Therapy (MOST) for improving social function in third level students
Study acronymPSYCHE-MOST
Study objectivesThe trial explores the feasibility and acceptability of delivering MOST to help-seeking university students who have recently attended student counselling for the purposes of improving social function. The main study hypothesis is that (a) it will be possible to recruit n=60 and retain a majority of these at follow up.
Ethics approval(s)

Approved 14/10/2020, Galway University Hospital Clinical Research Ethics Committee (Room 2, 2nd Floor, HR building, Merlin Park, Galway, H91N973, Ireland; +353 - 91 - 731990; colette.collins@hse.ie), ref: CA2468

Health condition(s) or problem(s) studiedMental health difficulties in third level students
InterventionThis trial is a pilot randomised controlled study recruiting young adults aged 18-35 years from a university student counselling service. The trial explores the feasibility, acceptability, and effectiveness of delivering MOST to participants who attended student counselling.

MOST (The intervention being assessed) consists of
(1) Interactive online therapy modules based on third wave cognitive behavioural therapy and primarily targeting social functioning by e.g., fostering self-efficacy (identifying personal strengths based on the strengths-based framework), positive emotions and subjective well-being (e.g., practicing mindfulness and self-compassion), or positive connections with others (e.g., focusing on empathy skills). Completing this therapy journey is supported by clinicians available by telephone/video chat on a for fortnightly basis.
(2) An online social network or ‘Café’ to foster social support. Participants are encouraged to communicate with one another and with peer and expert moderators. This is moderated by clinicians and led by ‘peer-support workers’ with lived experience and informed by the evidence-based problem-solving framework.
A further feature of MOST is an online group function to enable users to nominate issues (e.g., ‘how to break through shyness and make new friends?’), which are discussed in moderated groups through structured phases (e.g., brainstorming, pros and cons and wrap-up).

The intervention is 26 weeks duration. The follow up periods are 3 and 6 months post baseline. Randomisation is based on the sealed envelope online tool.
Intervention typeBehavioural
Primary outcome measureFeasibility outcomes:
Rates of recruitment and retention recorded using patient records at baseline, 3 months (12 weeks) and 6 months (26 weeks).
Secondary outcome measuresMeasured at baseline, 3 months (12 weeks) and 6 months (26 weeks) based on interview with the participant:

Demographic/Clinical measures:
1. Assessment interview (Demographic and clinical info)
2. DUDIT (Drug use)
3. AUDIT (Alcohol use)
4. Generalised Anxiety Disorder Assessment (GAD-7)
5. Patient Health Questionnaire (PHQ-9)
6. Time Use Survey
7. Social and Occupational Functioning Assessment Scale (SOFAS)
8. UCLA Loneliness scale

Cognition measures:
9. Reading the Eyes in the Mind
10. Test of premorbid functioning (TOPF)
11. Logical Memory (WMS)
Overall study start date01/09/2019
Completion date30/12/2025

Eligibility

Participant type(s)Learner/student
Age groupAdult
Lower age limit18 Years
Upper age limit35 Years
SexBoth
Target number of participants60
Key inclusion criteria1. Aged between 18 and 35 years of age,
2. Clinically stable and having the ability to give consent.
3. Self-reporting mental health difficulties of longer than one year in duration.
Key exclusion criteria 1. History of organic impairment (including IQ <70), or history of a head injury with loss of consciousness > 5-minute duration,
2. Drug or alcohol dependent.
Date of first enrolment01/04/2021
Date of final enrolment31/12/2024

Locations

Countries of recruitment

  • Ireland

Study participating centre

University of Galway Student counselling center
University Road
Galway
H91TK33
Ireland

Sponsor information

Ollscoil na Gaillimhe – University of Galway
University/education

University road
Galway
H91TK33
Ireland

Phone +353 91 524411
Email aoife.mckinley@universityofgalway.ie
Website https://www.universityofgalway.ie
ROR logo "ROR" https://ror.org/03bea9k73

Funders

Funder type

Government

Health Research Board
Government organisation / Local government
Alternative name(s)
Health Research Board, Ireland, An Bord Taighde Sláinte, HRB
Location
Ireland

Results and Publications

Intention to publish date01/12/2026
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high impact journal.
IPD sharing planThe datasets generated during and/or analysed during the current study will be available upon request from the study PI, Prof Gary Donohoe, gary.donohoe@universityofgalway.ie

Editorial Notes

19/04/2024: Trial's existence confirmed by Galway University Hospital Clinical Research Ethics Committee.